Potential Conflicts of Interest.
All authors: No reported conflicts of interest. All authors have
submitted the ICMJE Form for Disclosure of Potential Conflicts of
Interest. Conflicts that the editors consider relevant to the content of
the manuscript have been disclosed.
REFERENCES
- Goetz D and Ren CL. Review of Cystic Fibrosis. Pediatric Annals.
2019;48(4):e154-e161.
- Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient
Registry . 2011 Annual Data Report. Bethesda, Maryland, 2018.
- Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Clinical Practice
Guidelines for Pulmonary Therapies
Committee. Cystic
fibrosis pulmonary guidelines: treatment of pulmonary
exacerbations. Am J Respir Crit Care Med . 2009 Nov
1;180(9):802-8.
- Döring G, Flume P, Heijerman H, et al. Treatment of lung infection in
patients with cystic fibrosis: Current and future strategies. Journal
of Cystic Fibrosis. 2012. 11(6): 461-479.
- Lim S, Fitzgerald D. Treatment resistant Pseudomonas aeruginosa lung
disease in young children with cystic fibrosis. Paediatric Respiratory
Reviews. 2018 (27): 33-36.
- Winstanley C, O’Brien A, Brockhurst MA. Pseudomonas aeruginosa
Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic
Lung Infections. Trends in Microbiology. 2016. 24 (5): 327-337.
- Stefani S, et al. Relevance of multidrug-resistant Pseudomonas
aeruginosa infections in cystic fibrosis. Int J Med Microbiol. 2017:
307(6): 353-362.
- De Sutter P, Gasthuys E, Van Braeckel E et al. Pharmacokinetics in
Patients with Cystic Fibrosis: A Systematic Review of Data Published
Between 1999 and 2019. Clin Pharmacokinet (2020).
- Konold V, et al. Comparison of Population-Specific Cystic Fibrosis
Antibiograms Versus Hospital-Wide Antibiograms for Two Cystic Fibrosis
Centers. Open Forum Infectious Diseases . 2016;3(1):682.
- Hindler JF and Stelling J. Analysis and Presentation of Cumulative
Antibiograms: A New Consensus Guideline from the Clinical and
Laboratory Standards Institute. Clinical Infectious Diseases 2007;
44:867–73.
- Eyns H, Piérard D, De Wachter E, et al. Respiratory Bacterial Culture
Sampling in Expectorating and Non-expectorating Patients With Cystic
Fibrosis. Front Pediatr. 2018;6:403.
- Seidler D, Griffin M, Nymon A, et al. Throat Swabs and Sputum Culture
as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult
Cystic Fibrosis Patients. PLoS ONE. 2016;11(10): e0164232.
- Mogayzel PJ, Naureckas ET, Robinson KA, et al. Cystic Fibrosis
Foundation Pulmonary Guideline: Pharmacologic Approaches to Prevention
and Eradication of Pseudomonas aeruginosa Infection. Ann Am
Thorac Soc. 2014; 11(10): 1640-1650.
- Prevaes SM, de Steenhuijsen Piters WA, de Winter-de Groot KM, et al.
Concordance between upper and lower airway microbiota in infants with
cystic fibrosis. Eur Respir J. 2017 Mar 29;49(3):1602235.
- Ren CL, Morgan RL, Oermann C, et
al. Cystic
Fibrosis Pulmonary Guidelines: Use of CFTR Modulator Therapy in
Patients with Cystic Fibrosis. Ann Am Thorac Soc . 2018.